Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial
View/ Open
Volume
15
Pagination
1460 - 1468
DOI
10.1016/S1470-2045(14)71035-6
Journal
LANCET ONCOLOGY
Issue
ISSN
1470-2045